|
RRM2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.529900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.645800E-02 |
| Normal-vs-Stage2 |
3.379200E-01 |
| Normal-vs-Stage3 |
4.683800E-02 |
| Normal-vs-Stage4 |
9.232200E-01 |
| Stage1-vs-Stage2 |
5.546400E-01 |
| Stage1-vs-Stage3 |
8.483800E-01 |
| Stage1-vs-Stage4 |
1.084420E-01 |
| Stage2-vs-Stage3 |
5.160800E-01 |
| Stage2-vs-Stage4 |
4.223400E-01 |
| Stage3-vs-Stage4 |
1.164040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.273700E-02 |
| Normal-vs-AfricanAmerican |
3.532400E-02 |
| Normal-vs-Asian |
3.761600E-01 |
| Caucasian-vs-AfricanAmerican |
2.291400E-01 |
| Caucasian-vs-Asian |
5.618800E-01 |
| AfricanAmerican-vs-Asian |
1.357950E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.242000E-01 |
| Normal-vs-Female |
1.828450E-02 |
| Male-vs-Female |
1.687010E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.646080E-02 |
| Normal-vs-Age(41-60Yrs) |
1.154620E-01 |
| Normal-vs-Age(61-80Yrs) |
1.772400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.652000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.790800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.405400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.631600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.570200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.607400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.685600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.931000E-01 |
| Classical-VS-Follicular |
4.790800E-01 |
| Classical-VS-Other |
5.031400E-01 |
| Classical-VS-Normal |
1.228400E-02 |
| Tall-VS-Follicular |
6.971400E-01 |
| Tall-VS-Other |
7.729200E-01 |
| Tall-VS-Normal |
3.988200E-01 |
| Follicular-VS-Other |
6.917600E-01 |
| Follicular-VS-Normal |
1.686580E-01 |
| Other-VS-Normal |
8.410600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.968220E-01 |
| Normal-vs-N1 |
4.308000E-01 |
| N0-vs-N1 |
9.967000E-01 |
|
|
